Godlike Productions Banner
06:17 AM
Join Now, Free! (& No Ads) | FAQ | Links | Link to Us
 New! GLP YOUTUBE CHANNEL | GLP Radio! | Contact
  Tuesday, October 7, 2008  
  Breaking News     Back
Experimental Malaria Vaccine Proves Effective in Babies

VOA

2007-10-18

Researchers say an experimental malaria vaccine tested in Africa is safe and effective in babies, who are most at risk of dying of the disease. If all goes well, experts say the drug could become available in the next few years to protect infants and young children from the mosquito-borne illness. VOA's Jessica Berman reports.

Malaria kills more than one million people, each year, and makes 350 million others seriously ill. Most of the victims are small children and infants in Africa, where the mosquito-borne illness is endemic.

Now, researchers have announced the results of a clinical trial in Mozambique of an experimental vaccine. Two-hundred fourteen infants, ten to eighteen weeks of age, were tested.

Researchers found that - compared to those who were not vaccinated - the drug reduced the number of new infections in the infants by 65 percent, in a three month period.

Investigators say the vaccine also reduced the number of infants who became critically ill by 35 percent.

Ripley Ballou, of GlaxoSmithKline, is the maker of the experimental vaccine. Ballou notes that an earlier clinical trial involving one-to-four year olds showed the vaccine reduced the number of new infections by 45 percent.

"This is very encouraging news and I think it really sets the stage for the next step, which is to begin a phase three trial, a registration study of this vaccine in the second half of next year," said John McNeill, director of research and development for PATH Malaria Vaccine Initiative, which has provided financial support for development of the malaria vaccine.

The final clinical phase would involve as many as 16,000 children in seven African countries.

If all goes as well as expected, SmithKline plans to apply for regulatory approval, which could make the vaccine available within the next five years.

McNeill expects the three-shot vaccine regimen would be given to infants and children at the same time they receive other routine vaccinations against childhood illnesses.

"These are opportunities for immunizing kids that really provide us the chance to get the vaccine to the largest number of kids that need it," he said.

The results of the malaria vaccine trial are published in the British medical journal The Lancet.

  Email Article

  Discuss in the Forum

Back

Vote for Us!
Vote For Godlike Productions!
Vote for Us!  Valid HTML 4.01 Transitional



Disclaimer:
This website exists for entertainment purposes only. The reader is responsible for discerning the validity, factuality or implications of information posted here, be it fictional or based on real events. Moderators on this forum make every effort to review the material posted on this site however, it is not realistically possible for our small staff to manually review each and every one of the more than 5000 posts GodlikeProductions gets on a daily basis. The content of posts
on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of GodlikeProductions. This site may contain adult content and if you feel you might be offended by such content, you should log off immediately.

Not all posts on this website are intended as truthful or factual assertion by their authors. Some users of this website are participating in internet role playing, with or without the use of an avatar. NO post on this website should be considered factual information on face value alone. Users are encouraged to USE DISCERNMENT and do their own follow up research while reading and posting on this website. Godlikeproductions.com reserves the right to make changes to, corrections and/or remove entirely at any time posts made on this website without notice. In addition, Godlikeproductions.com disclaims any and all liability for damages incurred directly or indirectly as a result of a post on this website.

This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall Godlikeproductions.com be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.

Some events depicted in certain posting and threads on this website may be fictitious and any similarity to any person living or dead is merely coincidental. Some other articles may be based on actual events but which in certain cases incidents, characters and timelines have been changed for dramatic purposes. Certain characters may be composites, or entirely fictitious.

We do not discriminate against the mentally ill!

Fair Use Notice:
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
For more information please visit:
http://www.law.cornell.edu/uscode/17/107.shtml

This Disclaimer is subject to change at anytime.

Mail Webmaster with questions or comments about this site.

Page generated in 0.038s (1 queries)